Drug Target Review Antibodies ebook 2021
Within this ebook, find articles on how a lead bNAb candidate was identified to combat COVID-19 and why antibodies could present the answer to HIV treatment and vaccines.
Antibodies are a vital part of therapeutic treatment as researchers continue to make significant developments in the biologics field, especially as monoclonal antibodies (mAbs) show great promise.
Here, we discuss how a broadly neutralising antibody (bNAb) lead was created and selected with the potential to combat SARS-CoV-2 and results from two pre-clinical studies into how antibodies can be used as treatments and prophylactics for HIV.
Included in this ebook:
- Developing a broadly neutralising antibody therapeutic to combat SARS-CoV-2
Dr Laura Walker, Adagio Therapeutics
- Fighting HIV: could antibodies be the answer?
Victoria Rees, Drug Target Review